John Duncan Higgons Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Duncan Higgons.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Duncan Higgons. John Duncan Higgons is a Chief Operating Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Jounce Therapeutics, Inc. ($JNCE).
Address: C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE 02139 MA
Companies in which John Duncan Higgons is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Duncan Higgons: Chief Operating Officer
Holdings: 120,834 shares
Current Value: $5,367,446
Latest Transaction: Jan 05 2016
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Duncan Higgons: Director
Holdings: 9,713 shares
Current Value: $168,035
Latest Transaction: Apr 16 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John Duncan Higgons
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 10.00 | 200 | 2,000 | 9,713 | 9.9 K to 9.7 K (-2.02 %) |
| Mar 17 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 12.80 | 200 | 2,560 | 9,913 | 10.1 K to 9.9 K (-1.98 %) |
| Feb 18 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 11.78 | 200 | 2,356 | 10,113 | 10.3 K to 10.1 K (-1.94 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 11.11 | 200 | 2,222 | 10,313 | 10.5 K to 10.3 K (-1.90 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 12.00 | 1,500 | 18,000 | 10,513 | 12 K to 10.5 K (-12.49 %) |
| Jun 29 2020 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Option Exercise | A | 7.58 | 13,550 | 102,709 | 13,550 | |
| Jan 08 2020 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 8.11 | 1,500 | 12,165 | 12,013 | 13.5 K to 12 K (-11.10 %) |